Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFN 

Title
Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFN 
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 74, Issue 12, Pages 3205-3217
Publisher
American Association for Cancer Research (AACR)
Online
2014-04-16
DOI
10.1158/0008-5472.can-13-3461

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now